Reilly Financial Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $13K | Sell |
240
-112
| -32% | -$5.83K | ﹤0.01% | 661 |
|
|
2021
Q3 | $17K | Sell |
352
-204
| -37% | -$10.2K | ﹤0.01% | 560 |
|
|
2021
Q2 | $25K | Buy |
556
+316
| +132% | +$15.2K | ﹤0.01% | 494 |
|
|
2021
Q1 | $11K | Sell |
240
-204
| -46% | -$9.26K | ﹤0.01% | 675 |
|
|
2020
Q4 | $18K | Buy |
444
+204
| +85% | +$9.37K | ﹤0.01% | 514 |
|
|
2020
Q3 | $11K | Sell |
240
-76
| -24% | -$3.81K | ﹤0.01% | 552 |
|
|
2020
Q2 | $16K | Hold |
316
| – | – | ﹤0.01% | 489 |
|
|
2020
Q1 | $15K | Sell |
316
-216
| -41% | -$11.5K | ﹤0.01% | 479 |
|
|
2019
Q4 | $31K | Sell |
532
-24
| -4% | -$1.33K | ﹤0.01% | 416 |
|
|
2019
Q3 | $30K | Sell |
556
-204
| -27% | -$10.5K | ﹤0.01% | 429 |
|
|
2019
Q2 | $35K | Hold |
760
| – | – | ﹤0.01% | 422 |
|
|
2019
Q1 | $36K | Buy |
760
+204
| +37% | +$10.2K | ﹤0.01% | 410 |
|
|
2018
Q4 | $27K | Buy |
556
+36
| +7% | +$1.77K | ﹤0.01% | 429 |
|
|
2018
Q3 | $23K | Hold |
520
| – | – | ﹤0.01% | 517 |
|
|
2018
Q2 | $23K | Sell |
520
-30
| -5% | -$1.51K | ﹤0.01% | 460 |
|
|
2018
Q1 | $24K | Buy |
550
+204
| +59% | +$9.5K | ﹤0.01% | 437 |
|
|
2017
Q4 | $15K | Buy |
346
+30
| +9% | +$1.39K | ﹤0.01% | 564 |
|
|
2017
Q3 | $16K | Hold |
316
| – | – | ﹤0.01% | 545 |
|
|
2017
Q2 | $17K | Hold |
316
| – | – | ﹤0.01% | 539 |
|
|
2017
Q1 | $17K | Sell |
316
-80
| -20% | -$4.06K | ﹤0.01% | 509 |
|
|
2016
Q4 | $19K | Hold |
396
| – | – | ﹤0.01% | 457 |
|
|
2016
Q3 | $21K | Buy |
396
+236
| +148% | +$12.9K | ﹤0.01% | 403 |
|
|
2016
Q2 | $9K | Buy |
+160
| New | +$8.43K | ﹤0.01% | 519 |
|
|
2015
Q4 | – | Sell |
-156
| Closed | -$7.95K | – | 1279 |
|
|
2015
Q3 | $7K | Hold |
156
| – | – | ﹤0.01% | 875 |
|
|
2015
Q2 | $8K | Sell |
156
-280
| -64% | -$15.8K | ﹤0.01% | 935 |
|
|
2015
Q1 | $25K | Sell |
436
-506
| -54% | -$29K | ﹤0.01% | 600 |
|
|
2014
Q4 | $50K | Sell |
942
-215
| -19% | -$12K | 0.01% | 263 |
|
|
2014
Q3 | $66K | Sell |
1,157
-80
| -6% | -$4.9K | 0.02% | 217 |
|
|
2014
Q2 | $84K | Buy |
1,237
+123
| +11% | +$8.33K | 0.02% | 202 |
|
|
2014
Q1 | $74K | Buy |
1,114
+790
| +244% | +$53.4K | 0.02% | 220 |
|
|
2013
Q4 | $22K | Sell |
324
-258
| -44% | -$16.7K | 0.01% | 372 |
|
|
2013
Q3 | $37K | Hold |
582
| – | – | 0.01% | 260 |
|
|
2013
Q2 | $37K | Buy |
+582
| New | +$36.9K | 0.01% | 265 |
|
Other funds holding GSK
BCIM
Reilly Financial Advisors's GSK Position: Q4 2021 in Review
Reilly Financial Advisors reduced its GSK (GSK) stake by 32% in Q4 2021, selling an estimated $5.83K and leaving 240 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #661.
Reilly Financial Advisors first reported a position in GSK in Q2 2013 and has held it in 33 quarters since. The position peaked at $84K in Q2 2014. 920 funds tracked by Wall St. Rank hold GSK as of Q4 2021.
- Reilly Financial Advisors held 240 shares of GSK worth $13K as of Q4 2021.
- Reilly Financial Advisors sold 112 GSK shares in Q4 2021, an estimated $5.83K.
- GSK made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #661 holding.
- Reilly Financial Advisors first reported a position in GSK in Q2 2013 and has held it in 33 quarters since.
- Reilly Financial Advisors's GSK position peaked at $84K in Q2 2014.
- 920 funds tracked by Wall St. Rank held GSK as of Q4 2021.
Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.